Old Web
English
Sign In
Acemap
>
authorDetail
>
Christina Hebach
Christina Hebach
Novartis
Chemistry
Quinazoline
PI3K/AKT/mTOR pathway
Structure–activity relationship
Trifluoromethyl
5
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties
2016
Bioorganic & Medicinal Chemistry Letters
Klemens Hoegenauer
Nicolas Soldermann
Christina Hebach
Gregory Hollingworth
Ian Lewis
Anette Von Matt
Alexander Baxter Smith
Romain M. Wolf
Rainer Wilcken
Dorothea Haasen
Christoph Burkhart
Frédéric Zecri
Show All
Source
Cite
Save
Citations (16)
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
2016
ACS Medicinal Chemistry Letters
Klemens Hoegenauer
Nicolas Soldermann
Frédéric Stauffer
Pascal Furet
Nadege Graveleau
Alexander Baxter Smith
Christina Hebach
Gregory Hollingworth
Ian Lewis
Sascha Gutmann
Gabriele Rummel
Mark Knapp
Romain M. Wolf
Joachim Blanz
Roland Feifel
Christoph Burkhart
Frédéric Zecri
Show All
Source
Cite
Save
Citations (27)
Dérivés de quinazoline en tant que modulateurs des pi3k
2012
Pascal Furet
Christina Hebach
Klemens Högenauer
Gregory Hollingworth
Ian Lewis
Alexander Baxter Smith
Nicolas Soldermann
Frédéric Stauffer
Romain M. Wolf
Frédéric Zecri
Show All
Source
Cite
Save
Citations (0)
Nouveaux dérivés trifluorométhyl-oxadiazoles et leur utilisation dans le traitement de maladies
2012
Christina Hebach
Joerg Kallen
Joachim Nozulak
Marina Tintelnot-Blomley
Leo Widler
Show All
Source
Cite
Save
Citations (0)
Nouveaux dérivés de trifluorométhyl-oxadiazole et leur utilisation pour le traitement de maladies
2012
Christina Hebach
Émilie Joly
Joerg Kallen
James Gilbert Ternois
Marina Tintelnot-Blomley
Show All
Source
Cite
Save
Citations (0)
1